Inhibition of H-Y cell-mediated cytolysis by H-2Db antiserum by unknown
Brief Definitive Report 
INHIBITION  OF  H-Y  CELL-MEDIATED 
CYTOLYSIS  BY  H-2D b  ANTISERUM* 
BY GLORIA C. KOO, CARYN L. GOLDBERG,  AND FUNG-WIN SHEN 
From the Memorial Sloan-Kettering Cancer Center, New York 10021 
Cell-mediated cytolysis (CMC)  of male, H-Y positive cell, by female effector cells, 
is  subject  to  H-2  restriction  (1).  Furthermore,  skin  graft  rejection  caused  by  H-Y 
incompatibility is influenced by the H-2 type of both the male donor and the female 
recipient (2, 3). These facts led Ohno to surmise that the H-2-Fl2M complex might act 
as an anchorage site for H-Y at the cell surface (4). Both Beutler et al. (5) and Fellous 
et al.  (6)  later supported this idea by showing that  human  male cells of the Daudi 
line, whose  surfaces  do  not  incorporate  HLA-/?2M,  do  not  express  the  H-Y  +  cell- 
surface phenotype but are induced to do so when  fused with female cells expressing 
HLA-/?2M. Cocapping experiments with antisera to H-Y, fl2M (6), H-2 (7), and HLA 
(6)  have  not  resolved  the  question  whether  H-Y  and  H-2  are  in  fact  physically 
associated, and we have sought further evidence of the contiguity of H-Y and H-2 by 
determining whether  H-2  antiserum can  inhibit lysis of male target cells by female 
effector cells in  CMC  assays  (abbreviated as  H-Y  CMC).  We  looked especially for 
possible differences in inhibition by H-2D as compared with H-2K antibody because 
in mice of the strain we studied, C57BL/6  (B6), efficiency of H-Y CMC  depends on 
compatibility of target and effector cells for D  but not for K. 
Materials  and  Methods 
Mice.  C57BL/6  (B6)  mice  were  obtained  from  The Jackson  Laboratory,  Bar  Harbor, 
Maine. All other mice were obtained from E. A. Boyse at this Institute. 
CMC Assay.  The 5ZCr-release  CMC assay was performed essentially according to Gordon 
and Simpson (8). 
Target Cells (T).  B6  male  spleen  cells were  cultured  for  5  d  in  RPMI  (Grand  Island 
Biological Co., Grand Island, N.Y.)  supplemented with fetal calf serum  (15%),  glutamine (2 
mM), 2-mercaptoethanol (5 ×  10  -5 raM), penicillin, and streptomycin; concanavalin A (4 #g/ 
ml) was added on the 3rd d of culture. The cells were then washed once, labeled with 51Cr and 
suspended at a concentration of 1 ×  105 cells/ml for the CMC assay (8). 
Effector Cells (E).  B6 females, 2-3 mo old, were inoculated with  1  ×  107 B6 male spleen 
cells intraperitoneally. Spleen cells were harvested  1-8 wk later, cocultured for 5 d  in RPMI 
(supplemented as above) with irradiated B6 male spleen cells as described (8), and suspended 
at a concentration of 2-15  ×  10  s cells/ml for use in the CMC assay. 
Assay.  Equal volumes (50/~1 of target cells and effector cells) were placed in microtiter wells 
and incubated in 5% CO2 at 37°C for 4 h on a rocking platform. The supernates were harvested 
by the Titertek apparatus (Flow Laboratories, Inc., Roekville, Md.) and tested for 51Cr-release 
in a gamma counter (Packard Instrument Co., Inc., Downers Grove, Ill.). Each test was set up 
in triplicate. Results are expressed as: specific 5ZCr release percent --  100(A-B)/(C-B); where A 
=  epm test sample; B =  cpm spontaneous release with no effeetor cell; and C  ----  cpm maximal 
release (addition of 50/~1 of 1N HCL). 
* Supported in part by National Institutes of Health grants CA-08748, CA-22131, CA-22462, AI-00329, 
AI-11982, and American Cancer Society grant FRA-167. 
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TABLE  I 
Antisera 
1029 
l/cytotoxicity 
Specificity  Immunization  titers on B6 
LNC* 
a-H-2  d  B6 anti-BALB ascites sarcoma Meth. A.  < 10 
o~-D  b  (HTI ×  B6.I-I-2h)FI  anti-B6 leukemia EL4  300 
a-K  b  (BALB.G x  BI0.A)FI anti-BALB.B spleen and LNC  600 
* LNC, lymph node cells. 
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F,o.  1.  Inhibition  of  H-Y  cell-mediated  cytotoxicity,  B6~  anti-Bfx3  (H-2~),  by  D-region  H-2 
antibody. Each point is the mean of readings from seven separate tests (E:T  =  15:1). 
Corrected lysis percent  -- 
specific S~Cr release of test with a-D  b 
X  100. 
specific nlCr release of test with normal mouse serum (NMS) 
Control.  Female target cells were substituted for male target cells as a  control in every test;  in 
every case  100(A-B)/(C-B) with female cells was <5%. 
Antisera.  See Table I. 
Results 
Blocking of H-Y CMC by Antibody to D-region H-2 Antibody.  Fig.  1 shows the effect 
produced by adding to the H-Y CMC assay the antisera specified in Table I. Addition 
of antiserum to D-region H-2 antigen  (a-D  b)  inhibited lysis significantly at an assay 
dilution of 1:80 and almost completely at 1:20. The addition of K-region H-2 antibody 
(a-K  b)  did  not  inhibit  lysis and  titers of these  antisera  in  cytotoxicity assays were 
similar.  Lysis was not  inhibited  by NMS,  nor by the control  antiserum,  H-2  b anti- 
H-2  d, which could not react specifically with the cells, which were H-2  b (B6). Other 
antisera,  such  as  a-Thy-l.2  and  a-Ly-2.2 at  the  same dilutions,  had  no  inhibitory 
effect (data not shown). 
Specificity  of Inhibition  of H-Y CMC by D-region H-2 Antibody.  To  further  test  the 
antigenic specificity of inhibition of H-Y CMC by D b antibody, two portions of a-D  b 
serum were absorbed, one with BALB.G and the other with BALB male spleen and 
lymph node cells.  The H-2 haplotype of BALB.G is  H-2  g,  a  recombinant  between 
H-2  d (BALB) and H-2  b (C57BL) (9). Thus, BALB and BALB.G differ in the D-region 
of H-2 but are similar in the region I to K  inclusive. Absorption of c~-D  b serum with 
BALB.G, but  not  with  BALB, abolished  its capacity to inhibit  H-Y CMC  (Fig.  2). 1030  KOO  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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Fla.  2.  Specificity of inhibition by D-region H-2 antibody:  tests with ot-D  h serum  absorbed with 
BALB.G or BALB male cells. Each  point is the mean of readings from two separate tests (E:T  = 
15:1). 
Time Dependency of the Blocking of H- Y CMC by D b Antibody.  The following tests were 
conducted with a  view to obtaining evidence of the nature of the blocking of H-Y 
CMC by D b antibody. A block developing very rapidly might suggest that binding of 
D b antibody itself is sufficient to impede CMC; a longer time interval might suggest 
a  necessity for subsequent  events entailed by the binding of D b antibody.  Fig.  3 A 
shows a  progressive increase in lysis in H-Y CMC  assays terminated  1 through 4 h 
after initiation. Fig 3 B shows that blocking was progressively less effective when D b 
antibody was added to the 4-h CMC assays at intervals of 1, 2, and 3 h after initiation. 
The data shown in Fig. 3 C are critical, because they show that pre-exposure of target 
cells to  D b  antibody, followed by washing before the initiation of the standard  4-h 
assay, imposed a block to H-Y CMC that was relatively slow in developing. Blocking 
by pre-exposure of target cells to D b antibody was virtually complete, but only after 
an exposure time approaching 2 h. 
Discussion 
The finding that H-2D  b antibody inhibits H-Y-specific CMC by B6 effector cells, 
whereas H-2K  b antibody does not, corresponds with the features of H-2 restriction in 
this system, namely that compatibility for D b, but not for K b, is required for optimal 
H-Y specific cytolysis by B6 effector cells (1). This might imply that H-Y and D b are 
so closely situated in the plasma membrane that attachment of D b antibody impedes 
engagement of cytotoxic T  cells equipped to recognize a complex H-Y:D  b target, but 
certain  data  conflict with  so straightforward  an  explanation.  First,  blocking of an 
H-Y:D  b complex by D b antibody would take only a  few minutes, and yet maximal 
blocking of H-Y-specific CMC  by pre-ineubation with D b antibody required up to KOO  ET  AL.  BRIEF DEFINITIVE REPORT 
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Fno.  3.  Kinetics of the 4-h H-Y CMC assay and of its blocking by a-D  b antibody: (A) rate of lysis, 
(B) ot-D  b serum (final dilution =  1:20) was added at different times, and (C) target cells were pre- 
incubated (37°C) in a-D  b serum (final dilution =  1:20) washed, and used in the standard 4-h assay. 
Each point is the mean of readings from two separate tests (E:T =  8:1). 
2  h.  Furthermore,  Flaherty and  her colleagues have mapped  the relative positions of 
H-Y  and  D b,  using  fixed  cells,  and  find  that  they  are  not  contiguous,  although 
H-Y antibody applied to unfixed cells initiates a  rearrangement  that  brings H-Y and 
D b into close proximity.  Because approximation  of H-Y and  D b can also be induced 
by testosterone, ~ and  because  rearrangements  of this kind evidently affect particular 
components  of the plasma  membrane  in  an  orderly  manner  (10), 1 it seems  unlikely 
1 Flaherty,  L.,  D.  Zimmerman,  and  S.  S.  Wachtel.  1979. H-Y  antigen:  cell surface  mapping  and 
testosterone-induced supramolecular repatterning.J. Exp. Med. 150.1020. 1039  KOO ET AL.  BRIEF  DEFINITIVE REPORT 
that such adjustments in the display of surface molecules are serological artifacts. We 
propose that  H-Y and  H-2D  b normally are  not  closely adjacent,  but  become so in 
response to activators. The question whether this change in configuration of the target 
cell  surface  is  an  incidental  or  necessary  event  in  H-Y-specific  CMC  cannot  be 
answered at the present  time. 
Summary 
Assays of H-Y-specific cell-mediated cytolysis (CMC) in vitro were carried out with 
B6  female  effector  cells  and  B6  male  target  cells.  This  lytic  system  depends  on 
compatibility  for H-2D  b but  not  for H-2K  b.  Antibody to H-2D  b but  not  to  H-2K  ~ 
blocked the CMC assay. However, maximal blocking required exposure of the target 
cells  to  H-2D  b antibody  for up  to  2  h.  This  interval  is  far  longer  than  would  be 
required for blocking of a pre-existing H-Y:H-2D  b complex, and seems more consonant 
with a membrane reorganization bringing H-Y and H-2D  b together, as proposed from 
mapping studies. The question whether the postulated configurational change affect- 
ing H-Y and H-2D  b is a  necessary feature of CMC awaits further study. 
Received  for publication 31 May 1979. 
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